Anatomic Pathology Market worth $46.8 Billion by 2025 | at a CAGR of 7.1%
The growth in this market is majorly driven by the high incidence of cancer and other target diseases, availability of reimbursement, and the growing focus on personalized medicine. However, the availability of refurbished products, the lack of skilled professionals, and product recalls are expected to hamper the market growth to a certain extent during the forecast period.
[306 Pages Report] The global...
Anatomic Pathology Market | Key Players Thermo Fisher Scientific, Danaher Corporation, Agilent Technologies, Sakura Finetechnical Co Ltd, Quest Diagnostics Incorporated
Growth can be attributed to increasing ageing population; increasing prevalence of chronic diseases and the subsequent growth in the number of anatomic pathology tests. For instance, According to the WHO, the population aged 60 years and over across the globe is expected to double from about 11% in 2000 to 22% in 2050. The number of people over 60 years of age will increase from 605 million to 2 Billion...